{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:32:41Z","timestamp":1791822761100,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,7]]},"DOI":"10.7759\/cureus.48463","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T21:55:27Z","timestamp":1699394127000},"source":"Crossref","is-referenced-by-count":3,"title":["Inflammatory Myositis Following Statin Use in a Patient With Untreated Hypothyroidism"],"prefix":"10.7759","author":[{"given":"Mellisa","family":"Renteria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misbah","family":"Jilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Brockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry E","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg IE","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, et al.. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021, 7:86. 10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach Y","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020, 16:689-701. 10.1038\/s41584-020-00515-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.101484","article-title":"Inflammatory muscle disease - An update","volume":"34","author":"Baig S","year":"2020","unstructured":"Baig S, Paik JJ. Inflammatory muscle disease - An update. Best Pract Res Clin Rheumatol. 2020, 34:101484. 10.1016\/j.berh.2019.101484","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1440206","article-title":"Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations","volume":"14","author":"Selva-O'Callaghan A","year":"2018","unstructured":"Selva-O'Callaghan A, Alvarado-Cardenas M, Pinal-Fern\u00e1ndez I, et al.. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations. Expert Rev Clin Immunol. 2018, 14:215-24. 10.1080\/1744666X.2018.1440206","journal-title":"Expert Rev Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-00676-2","article-title":"Autoimmune myopathies: updates on evaluation and treatment","volume":"15","author":"McGrath ER","year":"2018","unstructured":"McGrath ER, Doughty CT, Amato AA. Autoimmune myopathies: updates on evaluation and treatment. Neurotherapeutics. 2018, 15:976-94. 10.1007\/s13311-018-00676-2","journal-title":"Neurotherapeutics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.36185\/2532-1900-032","article-title":"Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications","volume":"39","author":"Dalakas MC","year":"2020","unstructured":"Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol. 2020, 39:289-301. 10.36185\/2532-1900-032","journal-title":"Acta Myol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111687","article-title":"Statin-associated myopathy: emphasis on mechanisms and targeted therapy","volume":"22","author":"Vinci P","year":"2021","unstructured":"Vinci P, Panizon E, Tosoni LM, et al.. Statin-associated myopathy: emphasis on mechanisms and targeted therapy. Int J Mol Sci. 2021, 22:10.3390\/ijms222111687","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158364","article-title":"Statins neuromuscular adverse effects","volume":"23","author":"Attardo S","year":"2022","unstructured":"Attardo S, Musumeci O, Velardo D, Toscano A. Statins neuromuscular adverse effects. Int J Mol Sci. 2022, 23:10.3390\/ijms23158364","journal-title":"Int J Mol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1747431","article-title":"An overview of statin-induced myopathy and perspectives for the future","volume":"19","author":"Nikolic D","year":"2020","unstructured":"Nikolic D, Banach M, Chianetta R, et al.. An overview of statin-induced myopathy and perspectives for the future. Expert Opin Drug Saf. 2020, 19:601-15. 10.1080\/14740338.2020.1747431","journal-title":"Expert Opin Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2001.tb143683.x","article-title":"Statin-associated myopathy","volume":"175","author":"Hamilton-Craig I","year":"2001","unstructured":"Hamilton-Craig I. Statin-associated myopathy. Med J Aust. 2001, 175:486-9. 10.5694\/j.1326-5377.2001.tb143683.x","journal-title":"Med J Aust"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-915000537-2","article-title":"Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey","volume":"155","author":"Morris MS","year":"2001","unstructured":"Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis. 2001, 155:195-200. 10.1016\/s0021-915000537-2","journal-title":"Atherosclerosis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-8-200404200-00034","article-title":"Ezetimibe and statin-associated myopathy","volume":"140","author":"Fux R","year":"2004","unstructured":"Fux R, M\u00f6rike K, Gundel UF, Hartmann R, Gleiter CH. Ezetimibe and statin-associated myopathy. Ann Intern Med. 2004, 140:671-2. 10.7326\/0003-4819-140-8-200404200-00034","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2018.1531188","article-title":"Clinical significance of myositis-specific autoantibodies","volume":"41","author":"Nakashima R","year":"2018","unstructured":"Nakashima R. Clinical significance of myositis-specific autoantibodies. Immunol Med. 2018, 41:103-12. 10.1080\/25785826.2018.1531188","journal-title":"Immunol Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.025","article-title":"Diagnosis and management of immune-mediated myopathies","volume":"92","author":"Milone M","year":"2017","unstructured":"Milone M. Diagnosis and management of immune-mediated myopathies. Mayo Clin Proc. 2017, 92:826-37. 10.1016\/j.mayocp.2016.12.025","journal-title":"Mayo Clin Proc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.038455","article-title":"Treatment of inflammatory myopathies","volume":"82","author":"Cordeiro AC","year":"2006","unstructured":"Cordeiro AC, Isenberg DA. Treatment of inflammatory myopathies. Postgrad Med J. 2006, 82:417-24. 10.1136\/pgmj.2005.038455","journal-title":"Postgrad Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-003-0053-1","article-title":"Idiopathic inflammatory myopathies: a treatment update","volume":"5","author":"Oddis CV","year":"2003","unstructured":"Oddis CV. Idiopathic inflammatory myopathies: a treatment update. Curr Rheumatol Rep. 2003, 5:431-6. 10.1007\/s11926-003-0053-1","journal-title":"Curr Rheumatol Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10313","article-title":"Inflammatory myopathies: clinical, diagnostic and therapeutic aspects","volume":"27","author":"Mastaglia FL","year":"2003","unstructured":"Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve. 2003, 27:407-25. 10.1002\/mus.10313","journal-title":"Muscle Nerve"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/162217-inflammatory-myositis-following-statin-use-in-a-patient-with-untreated-hypothyroidism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:45Z","timestamp":1707509445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/162217-inflammatory-myositis-following-statin-use-in-a-patient-with-untreated-hypothyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.48463","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}